Author:
Ma Shan-shan,Ho Seong-Hyun,Ma Su-yong,Li Yue-juan,Li Kai-tong,Tang Xiao-chuang,Zhao Guang-Rong,Xu Song-shan
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference15 articles.
1. Chemotherapy-associated hematopoietic toxicity;Kuhn;Am. J. Health Syst. Pharm.,2002
2. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy;Tepler;Blood,1996
3. A phase I trial of recombinant human interleukin-11 (Neumega, rhIL-11 growth factor) in women with breast cancer receiving chemotherapy;Gordon;Blood,1996
4. Clinical efficacy of rhIL-11;Reynolds;Oncology,2000
5. Enhanced pharmacological activity of recombinant human interleukin-11(rhIL-11) by chemical modification with polyethylene glycol;Takagi;J. Control. Release,2007
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献